ISDD
Formation
Presentation
Team teaching (.pdf)
Links
International
Inscriptions
Inscriptions M1
Inscriptions M2
ISDD-Macromolecules
PRESENTATION OF THE COURSE
(NEW 2019-2024)
RESEARCH COURSE (NEW 2019-2024)
Semester Summary (.pdf)
Detailed program UEs M1 (.pdf)
Detailed program UEs M2 (.pdf)
M1 Calender (2023-2024) (.pdf)
M2 Calender (2023-2024) (.pdf)
SCHEDULE
Schedule M1 (2022-2023)
Schedule M2 (2022-2023)
ISDD-Bioactive Molecules
PRESENTATION OF THE COURSE
(NEW 2019-2024)
RESEARCH COURSE (NEW 2019-2024)
Semester Summary (.pdf)
Detailed program UEs M1 (.pdf)
Detailed program UEs M2 (.pdf)
S1 Univ. Strasbourg
S2 Univ. Milan
S3 Univ. Paris Diderot
Schedule
Internships
Internships M1
InternshipsM2
Sponsors
Contacts
Stages
/
Stages M2 2019-2020
Liste des stages effectués - M2 Année 2019-2020
MAJ le 16/17/2021
Titres des stages
** Stages déja retenus
Stage 1 :
Analysis of chemical congeneric series from ChEMBL
(Encadré par : Henri Xhaard)
T. Binet
Stage 2 :
Structure-based approaches to identify new inhibitors of the genomic material recognition by of Respiratory syncytial Virus (RSV) polymerase
(Encadré par : Olivier Sperandio)
L. Checa Ruano
Stage 3 :
methods for Computational Protein Design
(Encadré par : Thomas Simonson)
E. Goulard Coderc
De Lacam
Stage 4 :
criblage rapide de librairies par les méthodes basées sur le potentiel ressenti d’une molécule
(Encadré par : Bruno CORNET)
Y. Nahal
Stage 5 :
Application of artificial intelligence (AI) techniques to automate pharmacokinetic model development
(Encadré par : Gerard JP van Westen)
K. Nguyen-Pham
Stage 6 :
Machine learning for the prediction of 2D6 inhibition
(Encadré par : Maria MITEVA)
M. Picard
Stage 7 :
Development of computational methods for improved drug discovery
Development of neural networks for drug discovery
(Encadré par : Nicolas Moitessier)
O. Rostaing
Stage 8 :
Targetting of NETosis through structure-based virtual ligand screening
structural bioinformatics – virtual screening – hit identification - lead optimization - direct binding analysis
(Encadré par : Gerry Nicolaes et Kanin Wichapong)
K. Sadaoui
Stage 9 :
Assessment of CES1 inhibition by drugs that could impact the clinical relevance of treatment
(Encadré par : Henrik Berg Rasmusen)
E. Briand
Stage 10 :
Development of computational methods for ADMET prediction
(Encadré par : Nicolas Moitessier)
A. Fayet
Stage 11 :
Theoretical investigation of pathologically-induced structural modifications of albumin
(Encadré par : Florent Di Meo)
M. Martin
Stage 12 :
Evaluation of binding affinity prediction methods for drug discovery and drug design
(Encadré par : Rippmann Friedrich)
K. Murdrovcic